HUTCHMED (China) Limited (HKG:0013)
27.68
-0.32 (-1.14%)
Sep 15, 2025, 4:08 PM HKT
HUTCHMED (China) Employees
HUTCHMED (China) had 1,811 employees as of December 31, 2024. The number of employees decreased by 177 or -8.90% compared to the previous year.
Employees
1,811
Change (1Y)
-177
Growth (1Y)
-8.90%
Revenue / Employee
2.66M HKD
Profits / Employee
2.06M HKD
Market Cap
22.73B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,811 | -177 | -8.90% |
Dec 31, 2023 | 1,988 | -37 | -1.83% |
Dec 31, 2022 | 2,025 | 265 | 15.06% |
Dec 31, 2021 | 1,760 | 480 | 37.50% |
Dec 31, 2020 | 1,280 | 427 | 50.06% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
BeOne Medicines AG | 11,000 |
JD Health International | 3,564 |
Hansoh Pharmaceutical Group Company | 8,989 |
Innovent Biologics | 5,659 |
Sino Biopharmaceutical | 24,379 |
WuXi Biologics | 12,575 |
Akeso | 3,035 |
CSPC Pharmaceutical Group | 21,400 |
HUTCHMED (China) News
- 3 days ago - Save the Date: HUTCHMED to Present R&D Updates on October 31, 2025 - GlobeNewsWire
- 10 days ago - HUTCHMED (China) Ltd (HCM) to Present New Data at Major Oncology Conferences | HCM stock news - GuruFocus
- 10 days ago - HUTCHMED Highlights Clinical Data to be Presented at the 2025 World Conference of Lung Cancer ... - GuruFocus
- 10 days ago - HUTCHMED Highlights Clinical Data to be Presented at the 2025 World Conference of Lung Cancer and the CSCO Annual Meeting 2025 - GlobeNewsWire
- 21 days ago - HUTCHMED CEO takes leave of absence; CFO Johnny Cheng appointed acting CEO - Seeking Alpha
- 21 days ago - HUTCHMED Announces CEO Leave of Absence and Interim Leadership Change | HCM stock news - GuruFocus
- 21 days ago - HUTCHMED Announces Appointment of Acting Chief Executive Officer - GlobeNewsWire
- 26 days ago - HUTCHMED Completes Patient Enrollment of SANOVO Phase III Trial of ... - GuruFocus